Inactivation of pathogens in blood and blood produ...[Med Health R I. 1998] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Click to change filter selection through MyNCBI.

1: Med Health R I. 1998 Dec;81(12):396-9.Links

Inactivation of pathogens in blood and blood products.

VITEX (V.I.Technologies, Inc.), New York, NY 10032, USA. ehud.ben-hur@vitechnologies.com

PMID: 9884539 [PubMed - indexed for MEDLINE]

Related articles

Viral inactivation of blood components: recent advances.
Transfus Clin Biol. 1996; 3(1):75-7.

[Transfus Clin Biol. 1996]
ReviewProtecting the blood supply from emerging pathogens: the role of pathogen inactivation.
Transfus Med Rev. 2005 Apr; 19(2):110-26.

[Transfus Med Rev. 2005]
ReviewVirus inactivation of fresh plasma.
Vox Sang. 1998; 74 Suppl 2:171-2.

[Vox Sang. 1998]
Pathogen inactivation: a new paradigm for blood safety.
Transfusion. 2007 Dec; 47(12):2180-4.

[Transfusion. 2007]
Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application.
Transfus Apher Sci. 2001 Dec; 25(3):179-81.

[Transfus Apher Sci. 2001]
» See reviews... | » See all...

Recent Activity

Clear Turn Off Turn On

Inactivation of pathogens in blood and blood products.Inactivation of pathogens in blood and blood products.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show